Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 4, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 February 2026 - 15:04

Human medicines European public assessment report (EPAR): Vanflyta, quizartinib, Date of authorisation: 06/11/2023, Revision: 4, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/vanflyta

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters